Portfolio
The following companies are members of the NewSpring Healthcare portfolio:
Core Essence Orthopaedics Inc.
Core Essence Orthopaedics, Inc. (CE Ortho) is a privately held orthopaedic device company focused on the development, manufacture and commercialization of solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair for the extremity market. CE Ortho’s intuitive and innovative technologies are driven by increasing demands for alternatives to complicated surgical procedures. CE Ortho devices enable surgeons to build on classic and familiar surgical techniques with novel instruments and implants that simplify procedures and can be mastered quickly. The Company’s proprietary technologies provide solutions to the growing volume of tendon and ligament repairs required by the active lifestyles of patients of all ages. www.ceortho.com.
CorridorPharma
Corridor Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics for pulmonary arterial hypertension (PAH) and other vascular diseases based on its proprietary serotonin antagonist and arginase inhibition platforms. In June 2010, Corridor was formed by the merger of Immune Control and Arginetix. www.corridorpharma.com
EKR Therapeutics
EKR was founded to provide prescription products and therapeutic solutions that support and improve the quality of life of cancer patients. Oncology supportive care is becoming an increasingly critical component in support of patients as they progress through the complex arena of oncology treatment.The management team of EKR believes that cancer survival is largely impacted by the appropriate management of side effects encountered by patients undergoing therapy. EKR Therapeutics is committed to collaborating with the full scope of healthcare practitioners in helping patients adhere to primary treatment through the use of supportive care products. www.ekrtx.com
Habit Opco
Habit Opco, Inc., based in Boston, MA, is one of the largest accredited healthcare organizations in New England providing multi-disciplinary treatment services on an outpatient basis to individuals addicted to drugs enabling them to function normally in society. Habit provides comprehensive services to individuals addicted to opiates and currently operates 12 sited programs and two mobile van units. www.habitopco.com
MinSec Holdings, Inc.
MinSec Holdings Inc., a private company, incorporated in Delaware and headquartered in Wallingford, Pennsylvania, was founded in 1995 by a father and son team John McDougall and Sean McDougall. The Company primarily operates Community Corrections Facilities, Behavioral Health Treatment Centers, and Outpatient Programs for the treatment of chemical dependency and mental health disorders. Through its residential programs, inmates receive individual assessment and rehabilitation services along with appropriate counseling, chemical dependency treatment, educational and vocational assessment and mental health and behavioral health management. Outpatient services allow MinSec to provide the full continuum of care with treatment for substance abuse that includes special emphasis on related criminal behaviors and relapse prevention. MinSec’s residents are typically adult males serving the last three to six months of their sentence and who are preparing for re-entry into society at large. MinSec’s outpatient population consists primarily of offenders released on probation or parole. To learn more about MinSec Holdings, Inc., please visit the company’s website at www.minsec.com.
Nitric BioTherapeutics
Nitric BioTherapeutics is a venture-backed biopharmaceutical company dedicated to exploring medical applications of topically applied gaseous Nitric Oxide (gNO). The Company will conduct clinical trials and commercialize gNO for the treatment of non-healing chronic wounds and for the treatment of other topical medical problems such as post-surgical infections.
www.nitricbio.com
Precyse Solutions
Precyse Solutions is the leader in driving peak performance within HIM departments of US health care facilities. Precyse’s technologies and services support best practices in multiple areas including: remote and on-site coding, transcription, audit and education, cancer registry, consulting and interim/long-term management services. www.precysesolutions.net
Putney, Inc.
Putney is a pharmaceutical company committed to providing high quality, cost-effective generic medicines for pets. Putney's reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. Putney's ongoing investment in research and development is focused on creating the next generation of generic veterinary products based on inputs from companion animal veterinarians and its industry partners. Learn more at www.putneyvet.com.
RedPath Integrated Pathology
RedPath Integrated Pathology, Inc., based in Pittsburgh, PA, is a national specialty laboratory that provides complex cancer diagnostic testing for pathologists, oncologists and clinicians. Its patented molecular-based analysis, PathFinderTG, integrates with routine pathology review of fixed slides, cytology and fluid specimens to render an early and definitive diagnosis where none would otherwise exist, thus improving patient outcomes and reducing healthcare costs.
www.redpathip.com
Salveo Specialty Pharmacy, Inc.
Salveo Specialty Pharmacy, Inc., a private company headquartered in Saint Petersburg, Florida, was formed to create a leading specialty pharmacy organization serving patients and customers across the country. Salveo will acquire, integrate and grow select specialty pharmacy organizations that share its philosophy of providing superior customer service and clinical patient care to the chronically ill population. With its initial acquisition of Echo Specialty Pharmacy Services in New York, Salveo currently serves over 6,500 chronic patients across multiple disease states.
Songbird Hearing
Songbird Hearing Inc. has developed the world’s only digital disposable hearing device offering consumers a solution that is low cost and high quality. The Company’s products allow the millions of consumers who want to hear better an avenue to ease their way into better hearing, without the hassles and commitments that come with traditional hearing aids. www.songbirdhearing.com
Sopherion Therapeutics
Sopherion develops novel anti-cancer therapies for patients suffering with advanced cancer,
including metastatic disease. The Company has an exclusive licensing agreement with Zeneus
Pharma Ltd. for the future commercialization of Myocet (a liposome-encapsulated
doxorubicin-citrate complex) in North America. The company also leverages its Minicell
Peptide Display screening technologies to identify additional therapies. Sopherion focuses
on research and development of new oncology compounds, employing its proprietary drug
discovery platform to develop novel specialty biopharmaceuticals, which it markets. www.sopherion.com
NEWSPRING HEALTHCARE - EXITS
